Zhi‐Ming Shao

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, Shandong Institute of Automation, Shanghai Institute of Nutrition and Health, Shanghai Cancer Institute, University of Chinese Academy of Sciences · ORCID：0000-0001-8781-2455

发表论文 386 篇 · 总被引 15344 次 · h-index 63

代表论文

• Breast cancer: pathogenesis and treatments (2025 · Signal Transduction and Targeted Therapy · 被引 858)
• Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer (2025 · New England Journal of Medicine · 被引 51)
• Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps (2025 · Cancer Cell · 被引 44)
• Evolving molecular subtyping of breast cancer advances precision treatment (2024 · Cancer Biology and Medicine · 被引 26)
• De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (2025 · UNC Libraries · 被引 17)
• Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study (2024 · EClinicalMedicine · 被引 15)